Saffola: Extending a Heart-Health Brand from Edible Oils into Health and Wellness Foods

Industry & Competitive Context

Saffola is owned by Marico, which reported a turnover of ₹108.3 billion in FY2024-25. Marico’s Q4 FY26 filing lists Saffola alongside Parachute, Hair & Care and a set of newer brands including True Elements, Plix and 4700BC. Saffola therefore operates inside a portfolio that Marico is deliberately widening beyond its coconut-oil and hair-oil core.

The category background goes back to 2010. Business Standard then described the health-food market as no longer niche, citing roughly 30 million known diabetics and at least 20 million patients of high cholesterol and blood pressure in India. In the same article, Sundrop was named as Saffola’s closest competitor in edible oils, with Saffola priced about 25% above it.

By FY24 Marico was sizing the opportunity much larger. As reported from its annual report, Marico said Saffola’s portfolio of healthy value-added foods had expanded the total addressable market to over ₹10,000 crore.

The competitive picture differs by category. In oats, a WARC-published agency case describes Kellogg’s and Quaker as Western master brands that came to dominate the breakfast category after Saffola’s 2010 entry.

Brand Situation Prior to Expansion

Saffola’s equity was narrow but deep. The brand began as an edible oil in the 1960s, and Marico began promoting it as a healthy-heart oil in the 1990s. Marico entered a registered-user agreement for the brand in 1990, and by 1993 Saffola was being manufactured in Marico’s own factories.

Marico built that proposition with institutions as well as advertising. It set up the Saffola Healthy Heart Foundation in 1991 and ran on-ground activations and mass-media campaigns. It put Saffola on TV in 2007 with the Saffola Life campaign, which invited people to take cholesterol tests. Business Standard reported more than 9 million participants. Trade coverage in 2006 described a shift from a curative to a preventive heart-care positioning.

Commercially, the oil franchise was strong and premium. In 2010 Business Standard reported a 53% share of super-premium edible oil, citing market estimates. Saffola contributed 27–30% of Marico’s turnover of ₹2,388 crore in 2008-09. A separate source reports Marico held about 73% of the super-premium refined oil segment until 2019. The two figures come from different sources and periods, and I have not reconciled them.

The brand also had limits. In late 2008-09 Saffola’s volume growth slipped to 9% or below, from a range of 15–20%, as the price gap to other branded oils widened. Marico cut oil prices by 10%, and management said growth recovered to 17–18%. The same article noted that Saffola could not go mass in distribution because of its premium slot. It was available through about 100,000 retail outlets, no more than 5% of kirana stores. Rivals quoted anonymously in the same piece questioned the strength of its health pitch.

Strategic Objective

Marico stated the objective in different words at different times. In 2010 Marico’s marketing head said the aim was to make Saffola a reference brand for any query about a healthy heart. He also said Marico had learned that it needed more than cooking oil to have a larger impact on consumers’ meals. Marico’s then consumer-products CEO, Saugata Gupta, said Marico had not leveraged Saffola enough as Indians became more health-conscious.

The current objective is expressed in financial terms. In its Q1 FY26 update Marico said Foods stood at 5x of FY20 revenues in FY25, above ₹900 crore. It aimed to grow Foods at 25%+ CAGR to about 8x of FY20 revenues in FY27, and to lift the India revenue share of Foods and Premium Personal Care to about 25% by FY27. By Q1 FY27 the stated targets were about 27% by FY27 and 33% by FY30. The MD and CEO said that perhaps three to four years from August 2025, Saffola foods could become bigger than Saffola edible oil. That is a management expectation, not a result.

Campaign Architecture & Execution

The expansion was not one campaign. It ran as a series of category entries with mixed results, in three phases.

Phase one: heart-adjacent functional foods. Marico extended the brand to low-sodium Saffola Salt Plus in 1998, to flour additives for cholesterol and diabetes management in 2007, and to Saffola Arise rice in 2010. The early volumes were small. Salt sold 150–200 tonnes a month and the flour additive 20–40 tonnes a month, and the article said the volumes were tiny. The same article also records a failed test. A salted baked snack, Saffola Zest, was test-marketed in Mumbai, consumers found it not tasty enough, and Marico sent it back to the laboratory.

Phase two: breakfast and everyday snacking. An agency case published by WARC says Marico extended Saffola into breakfast in 2010 but that the move was hasty and lacked direction, and that market share suffered as Kellogg’s and Quaker took the category. That account comes from an agency with a stake in the work and is a single source. Marico’s own later account is different in tone. It describes Saffola Oats as the 21st entrant in the plain oats market and says it studied Indian consumers’ preferences. It then built a savoury Masala Oats range and a millet-and-oats variant, Oats Gold. Marico later added sweet oats flavours such as Nutty Chocolate and Apple ’n’ Almonds. Marico announced, citing Kantar Household Panel data, that Saffola Oats had become India’s number one oats brand.

Phase three: wellness and convenience formats. In September 2020 Marico launched the Saffola ImmuniVeda Kadha Mix and Golden Turmeric Milk Mix, its entry into Ayurveda-based products, shortly after introducing Saffola Honey. Saffola Oodles entered instant noodles on a masala, wholegrain-oats base. Marico’s press release also lists Saffola MealMaker Soya Chunks. Saffola Cuppa Oats followed as a convenient snack format. In Q1 FY26 Marico reported launching Saffola Cold Pressed Oils, and said Saffola Muesli had healthy traction and added two variants. That last launch shows the expansion also moved back toward the original oil business with a new, premium offer.

Positioning & Consumer Insight

The documented insight behind the first extensions is behavioural. Marico said it realised through consumer interactions that cooking oil alone gave it a limited role in the meal, and that it wanted to reach the dining table. Analytically, this is a shift from owning an ingredient to owning a health occasion.

The brand’s promise has been framed as moving “from heart-care oil to better-for-you food”. Management now says Saffola offers better-for-you products and emphasises healthy choices at every stage of life. That wording is broader than “heart health”. It lets very different products carry one name, from oats and soya chunks to muesli and honey. theweek

The evidence also shows the limits of borrowed equity. The 2010 article warned that Saffola’s new products lacked significant entry barriers and could be replicated, and noted a competitor flour brand planned variants at far lower prices. The WARC account similarly says the brand’s first oats entry lost ground to established players. Taken together, the sources suggest the heart-health equity opened doors but did not guarantee success. Oats appears to have worked once product and flavour were adapted to the category. That is my reading of the sources, not a documented finding.

Media & Channel Strategy

Early communication used mass media and institutions. The Saffola Life TV campaign in 2007 and the Healthy Heart Foundation’s camps, plus a “State of the Indian Heart” study distributed to doctors, are documented. Marico’s stated logic was that doctors and heart patients would act as opinion leaders for functional foods.

Channels for the newer foods are documented more concretely. As reported from its annual report, Marico described a dedicated foods go-to-market focused on top specialty food stores, aiming for wider range availability, in-store execution and shopper engagement. Oodles was sold through Saffola’s own stores and major e-commerce platforms. Cuppa Oats was positioned for retail stores and quick-commerce platforms. Cold Pressed Oils were initially launched on e-commerce and quick-commerce platforms. At company level, Marico reported in Q1 FY27 that quick commerce grew by more than 50%. That figure is not Saffola-specific.

Business & Brand Outcomes

Scale. Per PTI, Marico’s Foods business crossed ₹900 crore in FY25, contributing 11% of domestic business and growing 33%, while Saffola edible oils contributed 19% of domestic business with low single-digit volume growth. The FY24 annual report coverage had put Saffola’s oil franchise at 23% of the domestic business. Both figures are shares of domestic business in their respective reports.

Trajectory. The path is uneven. In Q2 FY26 the foods portfolio grew 12% and crossed a ₹1,100 crore annualised run rate. In Q3 FY26 Foods grew 5%, which Marico described as consistent with calibrating franchise profitability as the business scales. In Q4 FY26 Marico reported high-teens value growth in Foods. In Q1 FY27 Foods grew 43% to a run rate above ₹1,300 crore, led by Saffola Soya Chunks, oats and muesli.

Profitability. Marico reported about 1,000 bps of structural gross-margin expansion in Foods over FY24 and FY25. It also said the Foods and Digital-first portfolios’ share of India Net Contribution had moved to double digits, about 5x of FY22 levels. Franchise-level profitability for Saffola foods alone is not disclosed.

Leadership claims. Marico reported Saffola Oats continued to gain market share on a MAT basis and retained the number-one oats position. The underlying Kantar data is not public, so this rests on Marico’s statement.

The oil business. In Q1 FY27 Saffola edible oils grew 7% in revenue while volumes fell by a high single digit because of supply rationalisation of select variants. ICICI Direct Research read this as a deliberate move away from low-margin variants toward higher-margin offerings such as cold-pressed oils. That is a brokerage’s interpretation, not Marico’s statement.

Strategic Implications

Brand equity transfers selectively. Saffola’s heart-health credibility supported entry into adjacent categories, but the documented record shows slow early volumes in salt and flour additives, a snack that was sent back for reformulation, and an agency account of an unfocused oats entry. A reasonable reading is that a trusted brand lowers the cost of trial but does not substitute for category-specific product work. Oats and masala oats seem to confirm this, because success followed adaptation to Indian taste preferences.

Broadening the promise was the enabling move. The language moved from heart health to better-for-you choices at every stage of life. That change expanded the set of products the name could credibly cover, but it also reduces the distinctiveness of the original claim. The sources do not show how that trade-off has played out in consumer perception.

The portfolio is reducing dependence on one category. Marico’s own targets assume a rising Foods and Premium Personal Care share of India revenue, and its CEO expects Saffola foods to overtake oils. Meanwhile management is trimming oil volumes to protect profitability. Together these show a company managing a legacy cash franchise and a growth franchise under one name.

Growth quality is still being proven. The FY26 pattern of 12%, then 5%, then high-teens, then 43% shows that scaling foods is not linear. Marico itself framed one weak quarter as a profitability calibration. Whether the Q1 FY27 acceleration holds is not yet known, and Foods figures include other brands.

Discussion Questions

1. Saffola’s early extensions (salt, flour additives, rice) stayed close to its heart-health promise but sold small volumes, while oats and masala oats moved further from it. What does that sequence suggest about how far a brand’s core promise should stretch, and what evidence in the case supports your view?

   
   

2. Marico’s wording shifted from heart health to “better-for-you products at every stage of life.” Evaluate the strategic gain and the risk of that broader promise for an incumbent premium brand.

   
   

3. Marico is reducing Saffola oil volumes in select variants while growing Foods. How should a company decide when to harvest a legacy franchise instead of defending its volume, and what additional information would you want from Marico?

   
   

4. Foods results include brands beyond Saffola, and Saffola-only financials are not public. How should an analyst assess the success of a brand extension when disclosure is portfolio-level, and which claims in this case can and cannot be verified?

   
   

5. Marico’s one documented failure signals (the Saffola Zest test, the agency’s account of the 2010 oats entry) came from a mix of company, press and agency sources. How much weight should each source type carry when building a strategic narrative, and how would you reduce bias in the case?